20 results about "Reduced fat" patented technology

The present application provides a kind of Laumei fruit vinegar beverage, is by Laumei fruit, brewing rice vinegar, yellow granulated sugar, honey proportion (weight ratio is 10:40:5:2) mixed after soaking, add appropriate amount of purified water and be made into.The Laumei fruit is the plant that Hubei Wudang mountain is unique, has generating effect of Xitie, clearing spirit and lowering qi, is called as holy fruit in ancient times, Ming Dynasty emperor Zhu Di also lists Laumei as tribute to the court.Fresh Laumei fruit contains rich phosphorus, iron, calcium, vitamin C, carotene and other nutrients and seventeen kinds of amino acids necessary for human body, has the effect of helping digestion, phlegm, kidney, refreshing, invigorating blood, strengthening body, tranquilizing pain, reducing pressure and reducing fat, also has the health care effect of anti-inflammatory analgesic, eliminating fatigue, detoxification, enhancing immunity, etc.The present application not only improves the utilization value of Laumei fruit, but also greatly improves the nutritional and health care function of Laumei fruit vinegar, low cost, improves the economic benefit, and creates good social benefit.

The application discloses a kind of medicine-food homologous compositions with the function of auxiliary reducing blood sugar and reducing fat, fermentation liquor and its preparation method and application.The application uses radix codonopsis, malt, lotus leaf, white kidney bean, hawthorn, radix puerariae as medicine-food homologous food material raw materials, mixed in proportion after water extraction, form medicine-food homologous composition with good function of reducing blood sugar and reducing fat, then form medicine-food homologous composition fermentation liquor with further improved function of reducing blood sugar and reducing fat after mixed bacteria fermentation.The application enhances the bioavailability of medicine-food homologous food material by microbial fermentation technology, and the prepared medicine-food homologous composition and fermentation liquor can be applied to the development of auxiliary reducing blood sugar and reducing fat functional products.

This invention discloses a probiotic protein V2016 and its application in the preparation of drugs for treating obesity, belonging to the field of biomedical technology. This invention provides a probiotic protein V2016, the amino acid sequence of which is shown in SEQ ID NO.1. Verification has shown that protein V2016 can efficiently and stably bind to the intestinal receptor ICAM-2, thereby significantly upregulating GLP-1 expression, mediating weight loss, reduced fat accumulation, and improved glucose tolerance; simultaneously, it can also reduce hepatic lipid deposition and inflammation, and promote thermogenesis activation in adipose tissue; at the intestinal microecological level, protein V2016 can improve the intestinal microenvironment, promote the enrichment of butyrate-producing bacteria in the intestine, thereby playing a role in regulating metabolism. In summary, the protein V2016 provided by this invention can be applied to the development of novel functional foods or weight-loss drugs.

1. Name of the design product: fat-reducing instrument. 2. Use of the design product: for promoting blood circulation, reducing fat, etc. 3. Design points of the design product: in shape. 4. Picture or photo best indicating the design points: perspective view.

The application discloses a whipping cream and a preparation method thereof. The application uses casein in milk to prepare a whipping cream with a low fat content without using non-milk protein and non-milk oil and fat raw materials. First, transglutaminase is used to promote the intermolecular crosslinking of casein, so that the crosslinking state of casein is increased. Then, the combination of casein components with different crosslinking states is used to prepare a whipping cream, so that the problem that a whipping cream with a low fat content cannot form a foam structure or has poor foam stability is solved, and a whipping cream with a reduced fat content is obtained. Meanwhile, the reduction of the fat content can meet the demand of consumers for health and improve the life quality of people.

The application discloses a high internal phase water-in-oil emulsion and application of the high internal phase water-in-oil emulsion as a fat substitute in salad dressing, and belongs to the technical field of fat substitutes. The preparation of the high internal phase water-in-oil emulsion comprises the following steps: dissolving dioscin and SP in chloroform, and then evaporating the chloroform to obtain DGSP particles; dispersing the prepared DGSP particles in rapeseed oil, and then dispersing a water phase drop by drop into the rapeseed oil to obtain a water-oil mixture, and then performing shearing emulsification to obtain W / O-HIPE. The oil gel-based W / O-HIPE with DGSP particles is used as a fat substitute to prepare a fat-reducing salad dressing, so that the fat-reducing salad dressing can have similar performance to normal salad dressing while reducing fat.

The application discloses a traditional Chinese medicine formula for treating simple obesity by consolidating the root and removing turbidity, a preparation process and application thereof, and belongs to the technical field of traditional Chinese medicine. The formula is composed of raw astragalus, dried tangerine or orange peel, tuckahoe, fried seed of Chinese yam, gordon euryale seed, Chinese yam, lotus leaf, fried cassia seed, fried hawthorn fruit and cassia bark in a specific ratio and has the effects of benefiting qi, strengthening the spleen, removing turbidity and reducing fat. The granules prepared from the formula contain 10g of crude drug per bag and are taken twice a day after meals for 4 weeks. Clinical preliminary observation shows that the average weight of simple obesity patients is reduced by 2.39kg after taking the medicine, which is obviously better than that of the comparison group (P<0.01), and no obvious adverse reactions are found. It is proved that the formula is safe and effective, and provides a treatment scheme with definite curative effect and high compliance for simple obesity patients.

This invention belongs to the field of formulated feed technology for marine fish, specifically relating to a feed for improving the muscle quality of *Hexagrammos oysterfish* and its preparation method. The feed for improving the muscle quality of *Hexagrammos oysterfish* is made from the following raw materials in the indicated weight percentages: 93.5%–96.5% basic ingredients, 1% compound vitamins, 1% compound mineral salts, and 1.5%–4.5% formulated feed composition, with the sum of the weight percentages of all raw materials being 100%. The formulated feed composition consists of yeast β-glucan, chitosan oligosaccharide, and coated sodium butyrate, with the mass ratio of yeast β-glucan, chitosan oligosaccharide, and coated sodium butyrate being 1–3:1–3:1–2. This invention not only effectively reduces fat deposition in the body of *Hexagrammos oysterfish*, improving its muscle elasticity and chewiness, but also significantly improves the textural properties of the fish meat, thereby enhancing the overall muscle quality of *Hexagrammos oysterfish* and meeting consumer preferences.

The application discloses a plant lactobacillus gasseri strain capable of transforming ginsenoside and cassia glycoside, and application of the strain in lipid reduction and alleviation of fatty liver, and belongs to the fields of microbial technology, medicine and functional food. The core feature of the strain is that the strain can not only transform ginsenoside Rb1 into ginsenoside Rd with higher activity, but also transform cassia glycoside into cassia glycoside base, thereby improving the efficacy. The animal experiment proves that the strain and the corresponding substrate are combined to play a better role in lipid reduction and liver protection: the serum total cholesterol and triglyceride levels of high-fat diet mice can be effectively reduced, and the liver weight, liver lipid deposition and liver tissue fatty degeneration can be reduced and improved. The strain provides a new core strain and technical scheme for developing microecological preparations for preventing and / or assisting in treating hyperlipidemia, non-alcoholic fatty liver and other metabolic diseases.

The application discloses a kind of crisp low-fat meat slice and preparation method thereof, belong to meat food and its processing technical field.The technical problem to be solved is to solve the technical problems or its combination in prior art, such as the product texture dry and hard caused by reducing fat content, not easy to achieve ideal crisp taste, and meat slice structure is not dense, not storage-resistant.The technical solution points include the following raw materials: fresh meat, soybean protein isolate, resistant dextrin, allulose, composite phosphate and seasoning accessories;The mass ratio of the fresh meat, resistant dextrin and allulose is 80-120:7-15:4-10;The crisp low-fat meat slice is prepared by gradient tumbling and gradient baking.

The present application relates to a kind of carbon fat-burning coffee beverage and its preparation method.The raw materials of the carbon fat-burning coffee beverage include composite coffee liquid, carbohydrate absorption inhibition composite system, fat metabolism promotion composite system, auxiliary material and water, the carbohydrate absorption inhibition composite system includes white kidney bean extract, green coffee bean extract and mulberry leaf extract, the fat metabolism promotion composite system includes medium-chain triglyceride and L-carnitine tartrate.In the carbohydrate absorption inhibition composite system, white kidney bean extract (alpha-amylase inhibitor), mulberry leaf extract (DNJ), green coffee bean extract (chlorogenic acid) are respectively targeted at starch, disaccharide, glucose hydrolysis and absorption link, and form full-link carbon interception;In the fat metabolism promotion composite system, medium-chain triglyceride (MCT) provides energy quickly to reduce fat, L-carnitine tartrate accelerates fatty acid beta-oxidation, and both consume stock fat.

The present application provides a kind of modulated milk and its preparation method, the raw material of the modulated milk includes: after protein deamidase enzymolysis cow milk;Wherein, the addition amount of protein deamidase is 0.3-1 ‰ by weight of the modulated milk;Enzymolysis temperature is 50-55 ℃, and enzymolysis time is 0.5-2.5 h.The present application is a kind of clean formula modulated milk, without additive, can effectively reduce the bitter taste caused by coffee in modulated milk, rich flavor, while product stability is good, can extend the shelf life of product, and there is no flocculation, delamination, precipitation and other phenomena appear in shelf life, greatly reduce the phenomenon of fat floating and coffee residue precipitation, and in high temperature sterilization process can reduce paste tube, improve the equipment operation efficiency, reduce the problem of product foreign matter and cleaning cost increase caused by paste tube.

The application discloses a polysaccharide with lipid-lowering and weight-reducing effects, and a preparation method and application thereof. The polysaccharide is obtained by extracting a crude extract from plant raw materials and performing multi-stage separation and purification, and has a single component with lipid-lowering and weight-reducing effects. The polysaccharide can reduce or control weight gain, reduce fat content or lipid load, improve or restore liver morphology, inhibit or reduce liver weight gain, inhibit or reverse liver steatosis, improve sugar and lipid metabolism, improve intestinal flora structure and the like.

1. Name of the design product: shaking machine. 2. Use of the design product: for reducing fat or exercise. 3. Design points of the design product: in shape. 4. Picture or photo that best shows the design points: design 1 perspective view. 5. Design 1 is designated as the basic design.

The present application provides a kind of coffee milk and its preparation method, which comprises: adding protein glutamine enzyme to milk for enzymolysis, then mixing with coffee raw materials, homogenizing and sterilizing to obtain coffee milk;The amount of protein glutamine enzyme added is 80-150 u / g protein, based on the total protein content of the milk.The present application is a clean formula coffee milk, which does not require additives, can effectively reduce the bitter taste of coffee, enrich the flavor, and has good product stability, can extend the shelf life of the product, and there is no flocculation, stratification, precipitation and other phenomena during the shelf life, greatly reducing the phenomenon of fat floating and coffee residue precipitation, and can reduce the paste pipe during high temperature sterilization treatment, improve the equipment operation efficiency, reduce the product foreign matter problem and increase the cleaning cost problem caused by paste pipe.

To provide polypeptides, and to provide use thereof in controlling blood glucose and / or reducing fat.SOLUTION: The present invention discloses a polypeptide and use thereof for controlling blood glucose and / or reducing fat. The amino acid sequence of the polypeptide includes any of the sequences of SEQ ID No.:1 to SEQ ID No.:4 or a sequence obtained by modifying at least one amino acid therein. The polypeptide disclosed in the present invention has a physiological activity that promotes fat metabolism and blood glucose control, so that by administering an effective amount of the polypeptide disclosed in the present invention or a composition containing the polypeptide to an individual, it is possible to effectively achieve the effect of treating or preventing diseases related to blood glucose imbalance or fat metabolism imbalance.SELECTED DRAWING: Figure 1

This invention relates to the field of biomedical technology, specifically to a drug for treating and preventing metabolic obesity caused by a high-fat diet. This invention provides a method to reduce... C2orf74 The use of compositions that reduce gene expression levels in the preparation of medicaments for the prevention and / or treatment of obesity, by utilizing the reduction of gene expression levels. C2orf74 In situ injection of a combination of gene expression levels into the testes of animals can prevent and treat obesity caused by a high-fat diet. Specifically, it can alleviate the obesity phenotype caused by a high-fat diet, including reducing weight gain, reducing fat accumulation, lowering serum triglyceride and cholesterol levels, improving blood glucose regulation and enhancing insulin sensitivity; and reducing the degree of fatty liver degeneration.